CAPA analysis of clotted red cell unit detected CAPA analysis of clotted red cell unit detected during leukodepletion process: Importance during leukodepletion process: Importance of quality check on blood collection monitors of quality check on blood collection monitors Sir, To ensure thorough anticoagulation of blood, its proper mixing with blood is essential during the whole blood (WB) collection process. Proper ratio of blood to anticoagulant and mixing are essential to prevent the start of blood coagulation process and to achieve standardized WB and its components, subsequently. This process can have critical consequences not only for the immediate quality of the resulting components but also for their long-term quality during storage. Blood collection monitors/mixers (BCM) are available and widely used to optimize WB collection process having set up alerts and intuitive instructions to guide the user throughout the draw process, with the view panel for easy viewing during donation. Regular quality check of equipment is must to prevent adverse event during any process.
At our center, an average of 90 blood units (WB) are collected every day in the 450 ml citrate-phosphate-dextrose with saline-adenine-glucose-mannitol triple blood bag system (Compofl ex; Fresenius Kabi, Germany) using BCM having auto mixing and auto clamping facility (Hemolight plus, Fresenius Kabi, Germany). We practice universal leukodepletion within 72 h of WB collection using separate laboratory leukodepletion fi lters (BioR 01 max BBS, Fresenius Kabi, Germany) for red cells and platelets using sterile connecting device (Compo Dock, Fresenius Kabi, Germany). We came across a red cell unit with a huge clot in the bag measuring 8 cm × 7 cm during the leukodepletion process on day 2 of blood collection [ Figure 1 ]. The clot was surprisingly missed during the collection and separation process. Bag was segregated, and other products of the same unit were identifi ed and quarantined. Blood culture of red cell unit and its components was done. BCM are checked weekly for volume limitation and agitations per minute using standard calibrated weights and stopwatch respectively. On corrective and preventive action analysis, it was found that red cell unit was prepared from a WB donation from a 29-year-old fi rst time male donor with the weight 83 kg, who completed the donation process (donor-in to donor-out) within 20 min. All the fi ve BCMs installed in the blood donor collection room were checked for movements and volume limitation and found that one of them was defective in agitation process with 15 agitation/ min while the normal range of agitation was 28-32/min; which led to incomplete mixing of anticoagulant to WB while there was no problem in auto clamping [ Figure 2 ]. This particular collection was collected on the malfunctioning BCM. This problem was encountered for the fi rst time; defective BCM was replaced by the alternate one till the problem was rectifi ed by the company engineer. Culture of red cell unit and its components was sterile.
Clots and fi brin strands in the blood units result from the activation of the clotting processes and can be a mixture of clotting proteins (including fi brin) and platelets. However, clots in the unit may also indicate bacterial contamination. In our case, clot formed was most likely due to the activation of clotting process as culture of red cell unit and its components was sterile. The necessary citrate concentration for prevention of activation process is much lower, but because of the risk of inadequate mixing and the biological variation of coagulation capacity among donors, a much higher concentration (1:14) is used. [1] [2] [3] If the citrate is not completely mixed with the blood immediately, during the blood collection process there will be inadequate anticoagulation and clump(s) formation which lead to loss of labile coagulation factors, loss of quality of platelets or even complete coagulation of the unit (clotted unit). Mixing devices are widely used to facilitate proper mixing of collected blood and anticoagulant to a similar level as that obtained by manual mixing. Regular quality control check of each BCM is must to ensure proper mixing of anticoagulant and blood to yield good quality products. De Korte et al. also suggest that most blood-mixing devices fail to mix efficiently at normal and low bleeding rates. [3] Quality control of BCM must include agitation counts for proper mixing using stopwatch and weighing the known standard weights for ensuring the volume limitations. Normal limits for the agitation should be 28-32/min while ±2% variation in weight is allowed. [4] Access this article online Access this article online Website: Website: www. ajts. org Evidence for an infl uence of secretor status on Evidence for an infl uence of secretor status on levels of the ABO-isoantibodies in serum levels of the ABO-isoantibodies in serum
Sir, ABO-isoantibodies are naturally occurring regular alloantibodies. They are developed during the early childhood of 3 months and remain good through adult life. The reactivity strength varies from one individual to another under the infl uence of the factors like age, sex. [1] The secretor status, characterized by a presence of ABH blood group antigens in saliva, is controlled by gene Se (FUT2) which codes for enzyme glycosyltransferase that assembles sugar molecules to confer the ABH blood groups antigen in body secretions including saliva. [2] The recessive allele se makes an individual nonsecretor in the homozygous state. In order to fi nd an infl uence of the secretor status on the levels of the ABO-isoantibodies, we tested 140 students at the Institute of Health Science, Muscat, in the age group of 17 years and above. Secretor status was determined on saliva using hemagglutination inhibition technique and was correlated with the level of the isoantibodies. The titer value of ≥ 128 was considered as high level while that of ≤ 64 was taken a low. [1] Statistical analysis was performed by 2 × 2 contingency table with Fisher's exact test. Of 140 subjects tested, 103 (73.6%) individuals were secretor and 37 (26.4%) were nonsecretor. Ninety-four of the participants showed high titer while 46 of those were with a low titer of isoantibodies. Interestingly, as many as 85 persons with high titer values belonged to the "secretor" category, whereas, 28 individuals classifi ed as "nonsecretor" had a low level of the antibodies. Statistical analysis showed the association as extremely signifi cant (P = 0.0001) [ Table 1 ].
A presence of hemolytic isoantibodies correlates with high titer. Grundbacher and Shreffl er [3] observed lower values of hemolytic anti-B among nonsecretors. In a similar note, Dube et al. [4] found a higher level of cold auto-anti-I among the secretors. Our observations on secretor status and the level of isoantibodies accord with these reported fi ndings.
Isoantibodies are stimulated by environmental antigens including microorganisms and provide natural immunity to a person. The individuals classifi ed as secretors with a greater level of isoantibodies may have the advantage of being protected from invading pathogens that may possess blood groups like antigen. Gershowitz and Neel [5] reviewed the rheumatic disease was frequently found among nonsecretors. Etiology of rheumatic disease is known for its prior exposure to streptococcal infection, and therefore, it is conceivable that the nonsecretors with a lower level of isoantibodies and immunoglobulins may have a lower resistance to infection. It appears that the gene responsible for Secretor status has a greater role to play beyond just exerting secretion of ABO antigens in saliva.
